128 related articles for article (PubMed ID: 8086505)
1. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A; Zintl F; Volm M
Ann Hematol; 1994 Sep; 69(3):111-5. PubMed ID: 8086505
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of resistance proteins in initial acute lymphatic leukemia (ALL) in childhood].
Sauerbrey A; Volm M; Zintl F
Klin Padiatr; 1995; 207(4):230-4. PubMed ID: 7564159
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
[TBL] [Abstract][Full Text] [Related]
4. Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia.
Volm M; Stammler G; Zintl F; Koomägi R; Sauerbrey A
Anticancer Drugs; 1997 Aug; 8(7):662-5. PubMed ID: 9311441
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia.
Volm M; Zintl F; Edler L; Sauerbrey A
Med Pediatr Oncol; 1997 Feb; 28(2):117-26. PubMed ID: 8986147
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.
Sauerbrey A; Stammler G; Zintl F; Volm M
Br J Haematol; 1996 Jul; 94(1):99-104. PubMed ID: 8757515
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study.
Dhooge C; De Moerloose B; Laureys G; Kint J; Ferster A; De Bacquer D; Philippe J; Benoit Y
Br J Haematol; 1999 Jun; 105(3):676-83. PubMed ID: 10354131
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A; Häfer R; Zintl F; Volm M
Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
[TBL] [Abstract][Full Text] [Related]
10. Identification of bladder cancer patients at risk for recurrence or progression: an immunohistochemical study based on the expression of metallothionein.
Hinkel A; Schmidtchen S; Palisaar RJ; Noldus J; Pannek J
J Toxicol Environ Health A; 2008; 71(13-14):954-9. PubMed ID: 18569601
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.
Siu LL; Banerjee D; Khurana RJ; Pan X; Pflueger R; Tannock IF; Moore MJ
Clin Cancer Res; 1998 Mar; 4(3):559-65. PubMed ID: 9533522
[TBL] [Abstract][Full Text] [Related]
12. Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress.
Goto H
Pediatr Int; 2015 Dec; 57(6):1059-66. PubMed ID: 26455582
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Münster Study Group.
Beyermann B; Adams HP; Henze G
J Clin Oncol; 1997 Jun; 15(6):2231-7. PubMed ID: 9196135
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio MT; Indolfi P
Oncol Rep; 2004 Dec; 12(6):1201-7. PubMed ID: 15547738
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
Ronson A; Tvito A; Rowe JM
Curr Oncol Rep; 2016 Jun; 18(6):39. PubMed ID: 27207612
[TBL] [Abstract][Full Text] [Related]
16. Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia.
Sauerbrey A; Sell W; Steinbach D; Voigt A; Zintl F
Br J Haematol; 2002 Jul; 118(1):147-50. PubMed ID: 12100141
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
19. Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone.
Felice MS; Zubizarreta PA; Alfaro EM; Sackmann-Muriel F
J Pediatr Hematol Oncol; 2001 Oct; 23(7):411-5. PubMed ID: 11878573
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
